Signals produced from these pathways may initiate the phenomenon of EMT and NED, and thus, novel combinatorial therapies effectively targeting JNK and Wnt-11, alongside other signalling mechanisms, may provide more effective treatment for PCa. This evidence concerns the gene WNT11 and posterior cortical atrophy.